Today is July 14, 2024. All times in Eastern Daylight Time.
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
06/14/2024 - 03:00 AM
BUSINESS WIRE
Immune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
06/14/2024 - 03:00 AM
BUSINESS WIRE
New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
06/14/2024 - 03:00 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:49 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:48 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:46 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:45 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:44 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/14/2024 - 02:42 AM
BUSINESS WIRE
Celltrion 賽特瑞恩在 EULAR 2024 上展示了 CT-P47(RoActemra® [托珠單抗]的生物相似藥)治療類風濕性關節炎患者的 III 期研究取得的積極成果
06/14/2024 - 02:18 AM
BUSINESS WIRE
1
...
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
« Previous
Next »